Literature DB >> 10375399

Myeloperoxidase-catalyzed oxidation of tyrosine.

M Tien1.   

Abstract

The oxidation of tyr by myleoperoxidase (MPO) is postulated to play a role in atherosclerotic plaque formation. MPO has been localized in plaques and a product of MPO-catalyzed oxidation of tyr, dityrosine, also found in plaques, is proposed to be a protein cross-linking agent. We have performed kinetic studies on the oxidation of tyr by MPO and investigated the role of substrate size on its oxidation. The kinetics of MPO-catalyzed oxidation of tyr where the tyr is free tyr, the dipeptides, tripeptides, and polypeptides were studied by stopped-flow methods. The rate of reaction with enzyme intermediates compound I and compound II are decreased with increasing substrate size. The amount of dityrosine formed was also decreased with increasing substrate size. The ability of sulfhydryl compounds to inhibit MPO-dependent dityrosine formation was investigated with reduced glutathione, cys, and met. Glutathione and cys both served as substrates for MPO compound I but not compound II, whereas met was not a substrate for either compound I or II. Met, an amino acid postulated to act as a "last chance" antioxidant for proteins, was not able to inhibit dityrosine formation from MPO-catalyzed oxidation of tyr. Glutathione and cys caused partial inhibition; however, it is possible that this inhibition was due to their ability to react directly with MPO rather than trapping the tyr radicals. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375399     DOI: 10.1006/abbi.1999.1226

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  The effect of neighboring methionine residue on tyrosine nitration and oxidation in peptides treated with MPO, H2O2, and NO2(-) or peroxynitrite and bicarbonate: role of intramolecular electron transfer mechanism?

Authors:  Hao Zhang; Jacek Zielonka; Adam Sikora; Joy Joseph; Yingkai Xu; B Kalyanaraman
Journal:  Arch Biochem Biophys       Date:  2008-11-24       Impact factor: 4.013

2.  Myeloperoxidase activity imaging using (67)Ga labeled substrate.

Authors:  Manel Querol Sans; John W Chen; Ralph Weissleder; Alexei A Bogdanov
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

3.  Reduction of ferricytochrome c by tyrosyltyrosylphenylalanine.

Authors:  S Hirota; H Okumura; S Kuroiwa; N Funasaki; Y Watanabe
Journal:  J Biol Inorg Chem       Date:  2005-05-03       Impact factor: 3.358

4.  Preparation of LDL , Oxidation , Methods of Detection, and Applications in Atherosclerosis Research.

Authors:  Chandrakala Aluganti Narasimhulu; Sampath Parthasarathy
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Kinetic and mechanistic considerations to assess the biological fate of peroxynitrite.

Authors:  Sebastián Carballal; Silvina Bartesaghi; Rafael Radi
Journal:  Biochim Biophys Acta       Date:  2013-07-18

6.  Protein nitration is predominantly mediated by a peroxynitrite-dependent pathway in cultured human leucocytes.

Authors:  Manuel Galiñanes; Bashir M Matata
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

7.  Inhibition of myeloperoxidase-mediated protein nitration by tempol: Kinetics, mechanism, and implications.

Authors:  Sandra M Vaz; Ohara Augusto
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-22       Impact factor: 11.205

8.  Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.

Authors:  Anna L P Chapman; Tessa J Mocatta; Sruti Shiva; Antonia Seidel; Brian Chen; Irada Khalilova; Martina E Paumann-Page; Guy N L Jameson; Christine C Winterbourn; Anthony J Kettle
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

9.  Peroxidative metabolism of beta2-agonists salbutamol and fenoterol and their analogues.

Authors:  Krzysztof J Reszka; Dennis W McGraw; Bradley E Britigan
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

10.  N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor.

Authors:  Hao Zhang; Xigang Jing; Yang Shi; Hao Xu; Jianhai Du; Tongju Guan; Dorothee Weihrauch; Deron W Jones; Weiling Wang; David Gourlay; Keith T Oldham; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  J Lipid Res       Date:  2013-07-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.